Search results
Mar 17, 2015 · PR Newswire. FRANKLIN LAKES, N.J., March 17, 2015 / PRNewswire / -- Becton, Dickinson and Company (NYSE: BDX) ("BD") today announced that it completed its acquisition of CareFusion Corporation ("CareFusion") pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement").
CareFusion was created in 2009 as a spinoff of medical technology businesses from Cardinal Health. [1] It began publicly trading on the New York Stock Exchange on September 1, 2009. [2] Cardinal's core business was drug distribution, a low-margin and low-risk, predictable business, with which the higher-margin, higher-risk medical technology ...
- 2009
- Medical Technology
- Acquired by Becton Dickinson in 2015
- Subsidiary
CareFusion, a BD company, is a global corporation serving the health care industry with products and services that help improve the cost and safety of health care for generations to come.
CareFusion proudly introduces the comprehensive line of high-quality, clinically-valued anesthesia delivery and patient monitor solutions from Vital Signs ® Vital Signs product categories include anesthesia consumables, airway access devices, patient monitoring, diagnostic cardiology (DCAR), perinatal monitoring and temperature management ...
CareFusion will operate as part of BD's Medical segment, and BD is committed to maintaining an active presence in San Diego where CareFusion is headquartered. Conference Call and Webcast Information. BD and CareFusion will conduct a live conference call and webcast on October 6, 2014, at 8:00 a.m. (ET).
Oct 6, 2014 · The BD-CareFusion deal joins a handful of other multibillion-dollar medtech mergers and acquisitions dealst that have made news this year, including Medtronic's planned $43 billion purchase of Covidien and Zimmer Holdings' plans for the $13.35 billion acquisition of the Biomet, the other big ortho device company headquartered in Warsaw, IN.
May 17, 2020 · Becton, Dickinson & Co. (NYSE: BDX) recently announced that it will be acquiring the San Diego biomedical business CareFusion (NYSE: CFN) for $12.2 billion. The purchase price is nearly three times CareFusion’s value on its first day of trading, when it closed with a market valuation of $4.2 billion. The deal, expected to close in the first ...
People also ask
What is CareFusion ®?
How much is CareFusion worth?
What's new at CareFusion?
Who advised CareFusion?
